US FDA approves Trogarzo, a new HIV drug „made-in-China“ (Taiwan)

Trogarzo™ (ibalizumab-uiyk) injection was developed by Taiwan’s Zhongyu New Drugs and is marketed in the US by Taiwan’s TaiMed Biologics. As a virus entry inhibitor,” ibalizumab binds to CD4, the major HIV receptor on the surface of T cells, to prevent these...

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny